Search

everythinglearnresearchcommunity

for

Search:↓

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

AGA risk factors include age, smoking, hypertension for men, and age, dyslipidemia for women; lifestyle changes may help prevention.

Women with non-classic congenital adrenal hyperplasia have higher risk for heart and metabolic problems.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Lower SHBG levels may increase the risk of PCOS.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Balding people may have higher heart disease risk.

Men with certain types of baldness at age 45 may have a higher risk of colon cancer and colorectal adenoma.

Hair loss increases with age; alcohol raises risk, more female partners lowers it.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Policemen have more hair loss due to obesity, sunlight exposure, and stress.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Bergamot may improve heart health, skin conditions, and mood, but more research is needed to confirm these benefits.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

Balding and low testosterone increase risk of urinary stones.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

Aromatase gene variation may increase female hair loss risk.

Some birth control pills have a higher risk of blood clots than others.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Irregular menstrual cycles in teenagers are linked to a higher risk of polycystic ovary syndrome and metabolic syndrome.

Low birthweight and rapid weight gain after birth may increase the risk of developing polycystic ovary syndrome.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

People with hidradenitis suppurativa often have lower vitamin D levels, weaker hip bones, and altered bone metabolism markers.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.